Sujoy Khan and Chronic - Free people check

(1 - 13 from 14

)

WAO International Scientific Conference 2012: Poster Sessions

wao.confex.com

2021: Efficacy of Montelukast As Add-On Therapy in Patients with Chronic Idiopathic Urticaria | Sujoy Khan (United Kingdom)

Chronic urticaria: Indian context-challenges and treatment options -...

pubmed.ncbi.nlm.nih.gov

Authors. Sujoy Khan , Anirban Maitra, Pravin Hissaria, Sitesh Roy, Mahesh Padukudru Anand, Nalin Nag, Harpal Singh. Affiliation. 1 Consultant Allergist ...

Efficacy of Montelukast as Added Therapy in Patients with Chronic...:...

www.ingentaconnect.com

$58.00+.00. © Bentham Science Publishers. Efficacy of Montelukast as Added Therapy in Patients with Chronic. Idiopathic Urticaria. Sujoy Khan. *,1 and Nuala Lynch. 1,2. 1Department of Immunology, Frimley Park Hospital NHS Foundation Trust, Portsmouth Road, Frimley, Surrey, ...

Chronic urticaria: Indian context-challenges and treatment options. |...

www.pubfacts.com

Urticaria is a common condition that occurs in both children and...

Chronic Urticaria: Indian Context—Challenges and Treatment Options

www.hindawi.com

Sujoy Khan, Anirban Maitra, Pravin Hissaria, Sitesh Roy, Mahesh PA, Nalin Nag have declared that they have no relevant conflict of interests. Harpal Singh is the Medical Advisor and Clinical Marketing Manager for Phadia India/IDD Thermo Fisher Scientific, the company that pioneered the ImmunoCAP technology for in-vitro allergy diagnostics.